Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 58

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1
Chunk 58
---
    $29,179 
  
    Joseph Jasper 
    $9,500  
    $9,450  
    $-  
    $7,795  
    $26,745 
  
    Robert Rudelius 
    $11,500  
    $9,450  
    $-  
    $7,795  
    $28,745 
  
    Spencer Breithaupt 
    $7,500  
    $9,450  
    $-  
    $6,344  
    $23,294 
  
    Diane Levitan 
    $5,000  
    $9,450  
    $-  
    $-  
    $14,450 
  
    Michael Eldred 
    $5,000  
    $9,450  
    $-  
    $37,080  
    $51,530 

    (1)
    The
    value in this column reflects the aggregate grant date fair value of the stock award as computed in accordance with ASC Topic 718.
    Information regarding the valuation assumptions used in the calculations are included in “Note 11 – Stockholder’s
    Equity” to our audited consolidated financial statements included in our 2025 Form 10-K. Share grants are issued at the beginning of each quarters’ board service period.

    (2)
    The
                                            value in this column reflects the aggregate grant date fair value of the stock options as
                                            computed in accordance with ASC Topic 718. Information regarding the valuation assumptions
                                            used in the calculations is included in “Note 11 – Stockholder’s Equity”
                                            to our audited consolidated financial statements included in our 2025 Form 10-K. As of March
                                            31, 2025, the aggregate number of options outstanding (vested and unvested) for Ms. Levitan
                                            was 35,954 and has been fully expensed in the past. Stock options for all other Board Directors were canceled in connection with
                                            the stock option buyout program.

    (3)
    The
    value in this column reflects the market value of restricted shares issued on the date of issuance.

General
Policy Regarding Compensation of Non-Employee Directors

Directors
who are not employees of the Company are paid director’s fees, in cash, stock awards, stock options, or a combination thereof.
In fiscal 2025, compensation was paid in cash